Chairman's Letter to Strategic Partners & InvestorsBuilding Trust
Building Trust
Before Scale.
In his Chairman's Letter to Strategic Partners & Investors, Sami Abdulhai outlines Green Path Medica's long-term vision for building a trusted healthcare platform across Saudi Arabia and the wider region through disciplined growth, strategic partnerships, operational excellence, and institutional thinking.
Explore the platform
KemphorVerkos LaboratoriosGruppo Farmaimpresa SrlNovarex Holdings
KemphorVerkos LaboratoriosGruppo Farmaimpresa SrlNovarex Holdings
By the numbers
$1.9M+
Market opportunity managed
5+
Strategic global partnerships
2030
Aligned with national vision
The Collection
Premier brands, scientifically curated.
Our portfolio represents the pinnacle of oral care and biotechnology, from the heritage of Laboratorios Verkos to Italian pharmaceutical excellence.
Saudi Vision 2030
Localizing Excellence.
Empowering the Kingdom.
Economic Diversification
Building local manufacturing capabilities for global healthcare brands within the GCC.
Health Transformation
Elevating the Saudi standard of care through ultra-premium consumer wellness portfolios.
92%
Regional growth YoY